当前位置 : 首页 > 市场合作 > 项目信息市场合作
Market cooperation| 发包方名称 | GWQ ServicePlus AG Postal |
| 发包方国别(国家/地区) | 德国 |
| 发包方座机 | |
| 发包方传真 | |
| 发包方邮箱 | |
| 发包方地址 | Tersteegenstraße 28 Düsseldorf DE Germany 40474 Germany |
| 发包方网址 | |
| 发包方联系人姓名 | GWQ ServicePlus AG |
| 发包方联系人座机 | +49 211758498- 0 |
| 发包方联系人手机 | |
| 发包方联系人邮箱 | |
| 项目名称 | Conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for finished medicinal products with the active ingredient teriparatide |
| 项目类型 | 其他 - 其他 |
| 项目预算¥ | |
| 项目投标截止时间 | 2022-11-10 |
| 项目开始时间 | |
| 项目结束时间 | |
| 服务商资质要求 | |
| 要求高匹配度成功案例个数 | |
| 项目交付地点 | |
| 是否准许转包或分包 | |
| 项目信息详述 | Section 130a (8) of the Social Code Book V enables the health insurance funds and pharmaceutical companies to conclude work discount agreements on the drugs to be dispensed at the expense of the statutory health insurance fund. GWQ acts as a company for efficiency and quality at KK in accordance with Section 130a, Paragraph 8, Sentence 5, SGB V, for its shareholder and customer accounts. With regard to the relevant legal regulations for the award of public contracts, a regular process of active ingredient-related, formal award procedures according to the regulations of the 4th part of the GWB takes place by GWQ ServicePlus AG. Until new drug discount agreements come into effect, the GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies as part of the open-house procedure for preparations with the active ingredient, among others. |
版权所有:天津市数字贸易综合服务平台 备案号:津B2-20080229-9